Our data showed that the most frequent tumor phenotype was represented by HER1+/HER2−/HER3−, and it was more frequently detected in the subgroup of poorly differentiated LSCC, characterized by the shortest RFS and OS, independently from the treatment protocols. The gene discussed is EGFR; the disease is neoplasm.